Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 34, Issue 2, Pages 81-91

ADAM 12: A Putative Marker of Oligodendrogliomas?

Dimitrios Kanakis,1 Uwe Lendeckel,5 Paraskevi Theodosiou,6 Henrik Dobrowolny,1 Christian Mawrin,2 Gerburg Keilhoff,4 Alicia Bukowska,3 Knut Dietzmann,2 Bernhard Bogerts,1 and Hans-Gert Bernstein1

1Department of Psychiatry, Otto-von-Guericke-University, Magdeburg, Germany
2Istitute of Neuropathology, Otto-von-Guericke-University, Magdeburg, Germany
3Institute of Experimental Internal Medicine, Otto-von-Guericke-University, Magdeburg, Germany
4Institute of Medical Neurobiology, Otto-von-Guericke-University, Magdeburg, Germany
5Institute of Experimental Internal Medicine, Ernst-Moritz-Arndt-University, Greifswald, Germany
6Department of Pathology and Cytology, University Hospital of Larissa, Larissa, Greece

Received 24 December 2012; Accepted 24 December 2012

Copyright © 2013 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Dimitrios Kanakis, Uwe Lendeckel, Paraskevi Theodosiou, et al., “ADAM 12: A Putative Marker of Oligodendrogliomas?,” Disease Markers, vol. 34, no. 2, pp. 81-91, 2013.